Erratum: Assessment concordance and predictive validity of self-report and biological assay of cocaine use in treatment trials (The American Journal on Addictions, (2014) 23, 5 (466-474), 10.1111/j.1521-0391.2014.12132.x);Assessment concordance and predictive validity of self-report and biological assay of cocaine use in treatment trials

American Journal on Addictions

Volumn 23, Issue 5, 2014, Pages 466-474

  Decker, Suzanne E ^a,b   Frankforter, Tami ^b   Babuscio, Theresa ^b   Nich, Charla ^b   Ball, Samuel A ^b,c   Carroll, Kathleen M ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c APT Foundation ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ARTICLE; BIOASSAY; COCAINE DEPENDENCE; EXPLORATORY RESEARCH; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SUBSTANCE USE; URINALYSIS; FEMALE; MALE; PREDICTIVE VALUE; PROCEDURES; SUBSTANCE ABUSE; URINE; VALIDATION STUDY;

COCAINE; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF REPORT; SUBSTANCE ABUSE DETECTION; URINE SPECIMEN COLLECTION;

EID: 84906334855     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12178     Document Type: Erratum

References (36)

1. Donovan DM, Bigelow GE, Brigham GS, et al. Primary outcome indices in illicit drug dependence treatment research: Systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction. 2012; 107: 694-708.
2. Nich C, Kiluk BD, Ball SA, et al., Towards identification of a reliable and clinically meaningful indicator of treatment outcome for drug addiction, Part 2: Empirical evaluation of cocaine outcome indicators. Under review.
3. Garcia-Fernandez G, Secades-Villa R, Garcia-Rodriguez O, et al. Individual characteristics and response to contingency management treatment for cocaine addiction. Psicothema. 2011; 23: 114-118.
4. Preston KL, Silverman K, Higgins ST, et al. Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol. 1998; 66: 691-696.
5. Schuler MS, Lechner WV, Carter RE, et al. Temporal and gender trends in concordance of urine drug screens and self-reported use in cocaine treatment studies. J Addict Med. 2009; 3: 211-217.
6. Fals-Stewart W, O'Farrell TJ, Freitas TT, et al. The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. J Consult Clin Psychol. 2000; 68: 134-144.
7. Babor TF, Steinberg K, Anton RF, et al. Talk is cheap: Measuring drinking outcomes in clinical trials. J Stud Alcohol. 2000; 61: 55-63.
8. Knight K, Hiller ML, Simpson DD, et al. The validity of self-reported cocaine use in a criminal justice treatment sample. Am J Drug Alcohol Abuse. 1998; 24: 647-660.
9. Zanis DA, McLellan T, Randall M,. Can you trust patient self-reports of drug use during treatment ? Drug Alcohol Depend. 1994; 35: 127-132.
10. Reisfleld GM, Goldberger BA, Bertholf RL,. ' False-positive' and 'false-negative' test results in clinical urine drug testing. Bioanalysis. 2009; 1: 937-952.
11. Cone EJ,. New developments in biological measures of drug prevalence. In:, Harrison L, Hughes A, eds. The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates, pp. 108-130. Rockville, MD: National Institute on Drug Abuse; 1997.
12. Huestis MA, Darwin WD, Shimomura E, et al. Cocaine and metabolites urinary excretion after controlled smoked administration. J Anal Toxicol. 2007; 31: 462-468.
13. Hersh D, Mulgrew CL, Van Kirk J, et al. The validity of self-reported cocaine use in two groups of cocaine abusers. J Consult Clin Psychol. 1999; 67: 37-42.
14. Schumacher JE, Milby JB, Raczynski JM, et al. Validity of self-reported crack cocaine use among homeless persons in treatment. J Subst Abuse Treat. 1995; 12: 335-339.
15. Chermack ST, Roll J, Reilly M, et al. Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug Alcohol Depend. 2000; 99: 43-49.
16. McKay JR, Alterman AI, Koppenhaver JM, et al. Continuous, categorical and time to event cocaine use outcome variables: Degree of intercorrelation and sensitivity to treatment group differences. Drug Alcohol Depend. 2001; 62: 19-31.
17. Tai B,. Appendix I: Workshop summary outcome measures and success criteria. In:, Tai B, Chiang N, Bridge P, eds. Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials, pp. 303-311. Rockville, MD: National Institute on Drug Abuse; 1997.
18. Vocci F, de Wit H,. Consensus statement on evaluation of outcome of pharmacotherapy for substance abuse/dependence: Report from a NIDA/CPDD meeting. 1999; National Institute on Drug Abuse Medications Development Division, Bethesda, MD.
19. McKay JR, Weiss RV,. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups: Preliminary results and methodological issues. Eval Rev. 2001; 25: 113-161.
20. Reiber C, Ramirez A, Parent D, et al. Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals. Drug Alcohol Depend. 2002; 68: 35-48.
21. McLellan AT, Alterman AI, Metzger DS, et al. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. J Consult Clin Psychol. 1994; 62: 1141-1158.
22. Carroll KM,. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, MD: NIDA; 1998.
23. Baker SM,. Twelve Step Facilitation Therapy for Drug Abuse and Dependence. New Haven, CT: Yale University PDC; 1998.
24. O'Malley SS, Carroll KM,. Psychotherapeutic considerations in pharmacologic trials. Alcohol Clin Exp Res. 1996; 20: 17A-22A.
25. Rounsaville BJ, Gawin FH, Kleber HD,. Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am J Drug Alcohol Abuse. 1985; 11: 171-191.
26. Carroll KM, Ball SA, Martino S, et al. Computer-assisted delivery of cognitive-behavioral therapy for addiction: A randomized trial of CBT4CBT. Am J Psychiatry. 2008; 165: 881-888.
27. Petry N, Peirce JM, Stitzer ML, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005; 62: 1148-1156.
28. Carroll KM, Fenton LR, Ball SA, et al. Efficacy of disulfiram and cognitive-behavioral therapy in cocaine-dependent outpatients: A randomized placebo controlled trial. Arch Gen Psychiatry. 2004; 64: 264-272.
29. McLellan AT, Luborsky L, Cacciola J, et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis. 1985; 173: 412-423.
30. Fleiss J,. Statistical Methods for Rates and Proportions. New York, NY: Wiley; 1981.
31. Vonmoos M, Hulka LM, Preller KH, et al. Data supplement to Cognitive dysfunctions in recreational and dependent cocaine users: Role of attention-deficit hyperactivity disorder, craving, and early age at onset. Br J Psychiatry. 2013; 203: 35-43. Accessed 10/18/13 at http://bjp.rcpsych.org/ content/suppl/2013/05/20/bjp.bp.112.118091.DC1.html.
32. Scheidweiler KB, Cone EJ, Moolchan ET, et al. Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration. J Pharmacol Exp Ther. 2005; 313: 909-915.
33. Cone EJ,. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients. Forensic Sci Int. 2012; 215: 88-91.
34. Carroll KM, Nich C, Ball SA, et al. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998; 93: 713-728.
35. Carroll KM, Nich C, Shi JM, et al. Efficacy of disulfiram and twelve-step facilitation in cocaine-dependent individuals maintained on methadone: A randomized placebo-controlled trial. Drug Alcohol Depend. 2012; 126: 224-231.
36. Carroll KM, Nich C, Petry NM, et al., (under review). Disulfiram and contingency management to enhance CBT for cocaine dependence.